In recent years, non-radioactive nucleic acid labeling and detection methodologies have become available in response to a desire by researchers and their institutions to move away from the use of radioisotopes. Advancements made in the areas of chemiluminescence and fluorescence have allowed for an easier transition. In non-radioactive assays, signal is generated through an enzymatic reaction with a chemiluminescent or chromogenic substrate: alternatively, detection can occur through the appropriate excitation and emission of a fluorophore-labeled probe.
The classification of non-radioactive nucleic acid labeling product includes biotin, DIG system, fluorescent and others. The proportion of DIG system in 2017 is about 33%, and the proportion is in increasing trend from 2013 to 2017.
Non-radioactive nucleic acid labeling product is widely used in DNA labeling, RNA labeling and oligonucleotide labeling. The most proportion of non-radioactive nucleic acid labeling product is used for DNA labeling, and the proportion in 2017 is about 56%.
United States is the largest sales place, with a sales market share nearly 43.73% in 2017. Following United States, Europe is the second largest Sales place with the Sales market share of 26.79%.

According to this study, over the next five years the Non-Radioactive Nucleic Acid Labeling Product market will register a 7.5% CAGR in terms of revenue, the global market size will reach US$ 370 million by 2024, from US$ 240 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Non-Radioactive Nucleic Acid Labeling Product business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-Radioactive Nucleic Acid Labeling Product market by product type, application, key manufacturers and key regions and countries.

This study considers the Non-Radioactive Nucleic Acid Labeling Product value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3: and forecast to 2024 in section 11.7.
Biotin
DIG System
Fluorescent
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4: and forecast to 2024 in section 11.8.
DNA Labeling
RNA Labeling
Oligonucleotide Labeling

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher Scientific
Roche
Promega
PerkinElmer
Agilent Technologies
General Electric
Enzo Biochem
Merck KGaA
Vector Labs
New England Biolabs

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Non-Radioactive Nucleic Acid Labeling Product consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Non-Radioactive Nucleic Acid Labeling Product market by identifying its various subsegments.
Focuses on the key global Non-Radioactive Nucleic Acid Labeling Product manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Non-Radioactive Nucleic Acid Labeling Product with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Non-Radioactive Nucleic Acid Labeling Product submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.